홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CRBU
#3068
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.55%
월간 변동
+21.79%
6달 변화
-5.94%
년간 변동율
+62.39%
이전 종가
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
양
25
마켓
주식
헬스케어
CRBU
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
90.55 M
93 M
93 M
93.12 M
93.47 M
—
Valuation ratios
Enterprise value
145.51 M
131.58 M
55.51 M
92.13 M
206.64 M
485.86 M
Price to earnings ratio
-1.24
-0.96
-0.56
-0.71
-1.37
-3.61
Price to sales ratio
14.4
14.37
8.37
12.67
23.16
58.57
Price to cash flow ratio
1.37
1.04
0.6
0.87
1.71
4.22
Price to book ratio
0.13
0.57
0.08
0.13
0.28
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.11
0.15
0.24
0.14
0.65
Return on equity %
0.12
0.14
0.18
0.33
0.19
0.84
Return on invested capital %
140.93
148.48
215.16
—
301.94
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 889.23
1 871.69
1 823.76
1 783.95
1 337.58
6 816.98
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 713.64
1 708.71
1 699.58
2 028.42
1 253.32
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.38
7.16
7.63
6.66
5.54
26.99
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.36
0.39
0.4
0.3
0.27
1.36
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.11
2.76
2.29
1.98
1.71
8.74
Net current asset value per share
2.62
2.43
2.34
2.07
1.67
8.51
Tangible book value per share
3.11
2.8
2.34
1.79
1.52
8.45
Working capital per share
2.27
2.09
2.04
1.76
1.37
7.25
Book value per share
3.11
2.8
2.34
1.79
1.52
8.45
뉴스
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences CLO, CRBU 주식 $13,598 상당 매도
Caribou Biosciences CLO sold $13,598 in CRBU stock
카리부 바이오사이언스 CTO, 616만원 상당 주식 매도
Caribou Biosciences CTO Kelly sells $6.1k in shares
Caribou Biosciences CMO, CRBU 주식 2.1천 달러 상당 매도
Caribou Biosciences CBO, 칸, 13,598달러 상당 주식 매도
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?